SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This ...
SAN FRANCISCO, Sept. 22, 2025 /PRNewswire/ -- A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This development offers ...
SAN DIEGO, Aug. 26, 2025 /PRNewswire/ -- Robbins LLP reminds investors who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) common stock between March 17, 2022 and September 22, 2022, ...
SAN FRANCISCO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- A federal court has reopened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, setting a new deadline of ...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between ...
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between ...
PHILADELPHIA, Aug. 19, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" ...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. (“Spectrum” or “the Company”) (NASDAQ: SPPI) for ...
Is the Turing test still relevant in today's AI landscape? The advent of large language models has challenged its importance. When you purchase through links on our site, we may earn an affiliate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results